Sofiva Genomics Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	86.79	90.61	112.08	96.81	119.81	214.99
Short-Term Investments	34.1	34.1	34.1	43.23	51.15	30.2
Cash & Short-Term Investments	120.89	124.71	146.18	140.03	170.96	245.19
Cash Growth	-4.95%	-14.69%	4.39%	-18.09%	-30.27%	11.94%
Accounts Receivable	64.91	62.07	65.94	75.95	75.16	74.04
Other Receivables	4.84	4.45	4.98	9.01	7.53	4.76
Receivables	69.75	66.52	70.92	84.96	82.68	78.8
Inventory	32.19	34.85	46.4	41.79	57.08	41.56
Prepaid Expenses	6.89	8.98	7.95	8.78	10.83	6.58
Other Current Assets	0.69	1.13	1.15	1.79	2.33	1.39
Total Current Assets	230.41	236.2	272.6	277.34	323.88	373.53
Property, Plant & Equipment	61.52	68.92	103.16	116.08	129.23	128.57
Long-Term Investments	401.89	385.39	368.02	348.09	333.32	297.35
Other Intangible Assets	8.17	5.15	8.19	6.86	6.61	6.23
Long-Term Deferred Tax Assets	5.09	5.38	5.06	9.31	6.65	8.91
Other Long-Term Assets	23.47	23.31	11.06	9.45	7.87	7.72
Total Assets	730.55	724.35	768.08	767.14	807.56	822.3
Accounts Payable	20.48	22.64	22.47	31.72	50.6	58.44
Accrued Expenses	20.76	24.47	33.1	37.15	36.48	30.52
Current Portion of Leases	13.51	13.73	16.43	14.43	14.16	14.48
Current Income Taxes Payable	0.73	0.73	-	-	-	4.22
Current Unearned Revenue	0.61	1.18	1.77	0.77	2.11	2.69
Other Current Liabilities	10.25	8.15	9.68	12.12	12.64	12.99
Total Current Liabilities	66.33	70.9	83.46	96.2	115.99	123.35
Long-Term Leases	18.57	21.8	36.95	49.15	60.52	71.45
Long-Term Deferred Tax Liabilities	0.13	0.14	0.24	0.25	0.62	-
Other Long-Term Liabilities	3.09	3.08	3.03	3.17	3.12	3.06
Total Liabilities	88.12	95.91	123.68	148.77	180.24	197.86
Common Stock	215.93	215.93	215.93	213.62	213.62	213.62
Additional Paid-In Capital	341.59	341.59	341.59	332.06	330.99	328.31
Retained Earnings	85.33	70.82	86.66	72.5	82.34	82.29
Comprehensive Income & Other	-0.18	-0.22	-0.15	-0.05	-0.03	0.01
Total Common Equity	642.67	628.13	644.04	618.14	626.92	624.23
Minority Interest	-0.24	0.31	0.36	0.23	0.4	0.21
Shareholders' Equity	642.44	628.43	644.4	618.37	627.32	624.44
Total Liabilities & Equity	730.55	724.35	768.08	767.14	807.56	822.3
Total Debt	32.08	35.53	53.38	63.59	74.67	85.94
Net Cash (Debt)	88.81	89.18	92.8	76.45	96.29	159.26
Net Cash Growth	12.93%	-3.90%	21.39%	-20.61%	-39.54%	35.02%
Net Cash Per Share	4.11	4.13	4.29	3.58	4.50	7.48
Filing Date Shares Outstanding	21.59	21.59	21.59	21.36	21.36	21.36
Total Common Shares Outstanding	21.59	21.59	21.59	21.36	21.36	21.36
Working Capital	164.08	165.3	189.14	181.14	207.89	250.18
Book Value Per Share	29.76	29.09	29.83	28.94	29.35	29.22
Tangible Book Value	634.51	622.98	635.85	611.28	620.3	618
Tangible Book Value Per Share	29.38	28.85	29.45	28.61	29.04	28.93
Machinery	144.43	144.43	167.48	157.43	144.6	115.73
Leasehold Improvements	27.83	27.97	28.15	28.33	29.91	29.33